References
- Elias SG, Adams A, Wisner DJ, Esserman LJ, van’t Veer LJ, Mali WP et al.: Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2014; 23: 1464–1483. doi: 10.1158/1055-9965.EPI-13-1170.
- Trop I, LeBlanc SM, David J, Lalonde L, Tran-Thanh D, Labelle M, El Khoury MM: molecular classification of infiltrating breast cancer: toward personalized therapy. Radiographics 2014; 34: 1178–1195. doi: 10.1148/rg.345130049.
- Cho N: Molecular subtypes and imaging phenotypes of breast cancer. Ultrasonography 2016; 35: 281–288. doi: 10.14366/usg.16030.
- Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T et al.: Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009; 27: 1160–1167. doi: 10.1200/JCO.2008.18.1370.
- Jackisch C, Harbeck N, Huober J, von Minckwitz G, Gerber B, Kreipe HH, Liedtke C et al.: 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus – Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast Care (Basel). 2015; 10: 211–219. doi: 10.1159/000433590.
- Rao A, Feneis J, Lalonde C, Ojeda-Fournier H: A pictorial review of changes in the BI-RADS fifth edition. Radiographics 2016; 36: 623–639. doi: 10.1148/rg.2016150178.
- Grimm LJ, Mazurowski MA: Breast Cancer Radiogenomics: Current status and future directions. Acad Radiol 2020; 27: 39–46. doi: 10.1016/j.acra.2019.09.012.
- Allison KH, Hammond ME, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL et al.: Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. J Clin Oncol 2020; 38: 1346–1366. doi: 10.1200/JCO.19.02309.
- Wolff AC, Somerfield MR, Dowsett M, Hammond ME, Hayes DF, McShane LM et al.: Human epidermal growth factor receptor 2 testing in breast cancer: ASCO-College of American Pathologists Guideline Update. J Clin Oncol 2023; 41: 3867–3872. doi: 10.1200/JCO.22.02864.
- Orrantia-Borunda E, Anchondo-Nuñez P, Acuña-Aguilar LE, Gómez-Valles FO, Ramírez-Valdespino CA: Subtypes of breast cancer. In: Mayrovitz HN, ed. Breast Cancer [Internet]. Brisbane (AU): Exon Publications; 2022 Aug 6. Chapter 3. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK583808/ doi: 10.36255/exon-publications-breast-cancer-subtypes. - Irshad A, Leddy R, Pisano E, Baker N, Lewis M, Ackerman S, Campbell A: Assessing the role of ultrasound in predicting the biological behavior of breast cancer. Am J Roentgenol 2013; 200: 284–290. doi: 10.2214/AJR.12.8781.
- Boisserie-Lacroix M, Macgrogan G, Debled M, Ferron S, Asad-Syed M, McKelvie-Sebileau P et al.: Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers. Oncologist 2013;18: 802–811. doi: 10.1634/theoncologist.2013-0380
- Celebi F, Pilanci KN, Ordu C, Agacayak F, Alco G, Ilgun S et al.: The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer. Diagn Interv Radiol 2015;21: 448–453. doi: 10.5152/dir.2015.14515.
- Tandon A, Srivastava P, Manchanda S, Wadhwa N, Gupta N, Kaur N et al.: Role of Sonography in Predicting the Hormone Receptor Status of Breast Cancer: A Prospective Study. J Diagn Med Sonogr 2018; 34: 3–14. doi: 10.1177/8756479317721663.
- Algazzar MAA, Elsayed EEM, Alhanafy AM, Mousa WA: Breast cancer imaging features as a predictor of the hormonal receptor status, HER2neu expression and molecular subtype. Egypt J Radiol Nucl Med 2020; 51: 93. doi: 10.1186/s43055-020-00210-5.
- Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Müller M: PROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12: 77. doi: 10.1186/1471-2105-12-77.
- Yang Q, Li HY, Liu D. Liu, Song YQ: Ultrasonographic features of triple-negative breast cancer: a comparison with other breast cancer subtypes. Asian Pac J Cancer Prev 2015; 16: 3229–3232. doi: 10.7314/apjcp.2015.16.8.3229.
- Wojcinski S, Soliman AA, Schmidt J, Makowski L, Degenhardt F, Hillemanns P: Sonographic features of triple-negative and non-triple-negative breast cancer. J Ultrasound Med 2012; 31: 1531–1541. doi: 10.7863/jum.2012.31.10.1531.
- Li JW, Zhang K, Shi ZT, Zhang X, Xie J, Liu JY, Chang C: Triple-negative invasive breast carcinoma: the association between the sonographic appearances with clinicopathological feature. Sci Rep 2018; 8: 9040. doi: 10.1038/s41598-018-27222-6. Erratum in: Sci Rep 2020; 10: 4468. doi: 10.1038/s41598-020-61260-3.
- Dogan BE, Turnbull LW: Imaging of triple-negative breast cancer. Ann Oncol 2012; 23: 23–29. doi: 10.1093/annonc/mds191.
- El-Maadaw SM, Gareer SW, Mikhael HS, Elkassas HH: Value of Breast Ultrasound in the Prediction of Molecular Subtypes in Patients with Breast Cancer. Menoufia Medical Journal 2023; 36. doi: 10.59204/2314-6788.1010.
- Zhu JY, He HL, Jiang XC, Bao HW, Chen F: Multimodal ultrasound features of breast cancers: association with molecular subtypes. BMC Medical Imaging 2023; 23: 57. doi: 10.1186/s12880-023-00999-3.
- Li X, Zhang J, Zhang G, Liu J, Tang C, Chen K et al.: Contrast-Enhanced Ultra-sound and Conventional Ultrasound Characteristics of Breast Cancer with Different Molecular Subtypes. Clin Breast Cancer 2024; 24: 204–214. doi: 10.1016/j.clbc.2023.11.005.
- Rashmi S, Kamala S, Murthy SS, Kotha S, Rao YS, Chaudhary KV: Predicting the molecular subtype of breast cancer based on mammography and ultrasound findings. Indian J Radiol Imaging 2018; 28: 354–361. doi: 10.4103/ijri.IJRI_78_18.
- Seo BK, Pisano ED, Kuzimak CM, Koomen M, Pavic D, Lee Y et al.: Association of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. Acad Radiol 2006; 13: 1211–1218. doi: 10.1016/j.acra.2006.06.015.
- Zhang L, Li J, Xiao Y, Cui H, Du G, Wang Y et al.: Identifying ultrasound and clinical features of breast cancer molecular subtypes by ensemble decision. Sci Rep 2015; 5: 11085. doi: 10.1038/srep11085.